Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Mumbai, India, Dec. 30, 2025 (GLOBE NEWSWIRE) -- HDFC ERGO General Insurance Company Limited shared an industry update on the growing momentum in green mobility insurance globally. Recent...
Read More -
On December 22, 2025, Azores Labs announced the nationwide U.S. availability of Jumpo, the company’s AI-powered kids camera.
Read More
-
Independent analysis examines CopperZen Compression Socks as nurses, office workers, and travelers evaluate 15-20 mmHg circulation support for 2026.
-
GenuinePurity Liposomal NMN analysis examines 250mg dosage research, liposomal absorption technology, and third-party verification in NAD+ category
-
NEW YORK and NEW ORLEANS, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
NEW YORK and NEW ORLEANS, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
NEW YORK and NEW ORLEANS, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
Industry analysis reveals why USP pharmaceutical-grade purity, third-party testing, and safety disclosures now define best methylene blue drops.
-
NEW YORK and NEW ORLEANS, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022...
-
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coupang, Inc. (NYSE: CPNG) between August 6, 2025 and...
-
Industry analysis compares FDA-approved Wegovy pricing from $149 oral to Ro's $199 injectable as telehealth access expands for 2026.